Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoki Fukuda

Showing results (21-30 of 107) with videos related to

Pageof 11
Sort By:
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|December 25, 2022
Assessment of the pneumonia severity score in community-acquired and nursing and healthcare-associated pneumonia due to COVID-19Naoyuki Miyashita, Yasushi Nakamori, Makoto Ogata, et al.
Respiratory Investigation|March 20, 2025
Characteristics of the 11th wave by SARS-CoV-2 KP.3 subvariant: Re-increase in pneumonia severityNaoyuki Miyashita, Yasushi Nakamori, Makoto Ogata, et al.
Oxford Medical Case Reports|June 2, 2020
Mycophenolate mofetil as a successful treatment of corticosteroid-resistant immune checkpoint inhibitor-induced hepatitisKenji Nakano, Masatoshi Nishizawa, Naoki Fukuda, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 23, 2022
Clinical features of nursing and healthcare-associated pneumonia due to COVID-19Naoyuki Miyashita, Yasushi Nakamori, Makoto Ogata, et al.
Respiratory Investigation|January 19, 2024
Nursing and healthcare-associated pneumonia due to SARS-CoV-2 Omicron variantNaoyuki Miyashita, Yasushi Nakamori, Makoto Ogata, et al.
Respiratory Investigation|January 7, 2024
Is the JRS atypical pneumonia prediction score useful in detecting COVID-19 pneumonia under nursing or healthcare settings?Naoyuki Miyashita, Yasushi Nakamori, Makoto Ogata, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 22, 2022
Early identification of novel coronavirus (COVID-19) pneumonia using clinical and radiographic findingsNaoyuki Miyashita, Yasushi Nakamori, Makoto Ogata, et al.
Journal of Clinical Medicine|February 25, 2022
Clinical Differences between Community-Acquired <i>Mycoplasma pneumoniae</i> Pneumonia and COVID-19 PneumoniaNaoyuki Miyashita, Yasushi Nakamori, Makoto Ogata, et al.
Viruses|June 28, 2023
Clinical Efficacy of the Neutralizing Antibody Therapy Sotrovimab in Patients with SARS-CoV-2 Omicron BA.1 and BA.2 Subvariant InfectionsNaoyuki Miyashita, Yasushi Nakamori, Makoto Ogata, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 19, 2022
Changes in diagnostic usefulness of the JRS scoring system in COVID-19 pneumonia by SARS-CoV-2 vaccinationNaoyuki Miyashita, Yasushi Nakamori, Makoto Ogata, et al.
Pageof 11

Showing results (21-30 of 107) with videos related to

Sort By:
Pageof 11
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|December 25, 2022
Assessment of the pneumonia severity score in community-acquired and nursing and healthcare-associated pneumonia due to COVID-19Naoyuki Miyashita, Yasushi Nakamori, Makoto Ogata, et al.
Respiratory Investigation|March 20, 2025
Characteristics of the 11th wave by SARS-CoV-2 KP.3 subvariant: Re-increase in pneumonia severityNaoyuki Miyashita, Yasushi Nakamori, Makoto Ogata, et al.
Oxford Medical Case Reports|June 2, 2020
Mycophenolate mofetil as a successful treatment of corticosteroid-resistant immune checkpoint inhibitor-induced hepatitisKenji Nakano, Masatoshi Nishizawa, Naoki Fukuda, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 23, 2022
Clinical features of nursing and healthcare-associated pneumonia due to COVID-19Naoyuki Miyashita, Yasushi Nakamori, Makoto Ogata, et al.
Respiratory Investigation|January 19, 2024
Nursing and healthcare-associated pneumonia due to SARS-CoV-2 Omicron variantNaoyuki Miyashita, Yasushi Nakamori, Makoto Ogata, et al.
Respiratory Investigation|January 7, 2024
Is the JRS atypical pneumonia prediction score useful in detecting COVID-19 pneumonia under nursing or healthcare settings?Naoyuki Miyashita, Yasushi Nakamori, Makoto Ogata, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 22, 2022
Early identification of novel coronavirus (COVID-19) pneumonia using clinical and radiographic findingsNaoyuki Miyashita, Yasushi Nakamori, Makoto Ogata, et al.
Journal of Clinical Medicine|February 25, 2022
Clinical Differences between Community-Acquired <i>Mycoplasma pneumoniae</i> Pneumonia and COVID-19 PneumoniaNaoyuki Miyashita, Yasushi Nakamori, Makoto Ogata, et al.
Viruses|June 28, 2023
Clinical Efficacy of the Neutralizing Antibody Therapy Sotrovimab in Patients with SARS-CoV-2 Omicron BA.1 and BA.2 Subvariant InfectionsNaoyuki Miyashita, Yasushi Nakamori, Makoto Ogata, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 19, 2022
Changes in diagnostic usefulness of the JRS scoring system in COVID-19 pneumonia by SARS-CoV-2 vaccinationNaoyuki Miyashita, Yasushi Nakamori, Makoto Ogata, et al.
Pageof 11